Dexcom (DXCM) Shares Outstanding (2010 - 2026)
Dexcom (DXCM) posted quarterly Shares Outstanding (Entity) of $412.4 million for Q2 2026, little changed year-over-year from $410.4 million in Q2 2025, and little changed quarter-over-quarter from $412.3 million in Q1 2026.
Dexcom (DXCM) Shares Outstanding (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Shares Outstanding (Entity) for 17 consecutive years, with $412.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) changed 0.49% year-over-year to $412.4 million; the TTM figure through Jun 2026 stood at $412.4 million (changed 0.49% YoY), while the FY2025 annual figure was $410.7 million, changed 0.44% from the prior year.
- Shares Outstanding (Entity) held at $412.4 million in Q2 2026 per DXCM's latest filing, from $412.3 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $412.4 million in Q2 2026 and bottomed at $392.4 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $404.2 million across 5 years, with a median of $408.5 million in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) climbed 3.56% — and 2024, when it grew 0.42%.
- Dexcom's Shares Outstanding (Entity) stood at $393.2 million in 2022, then rose by 3.56% to $407.2 million in 2023, then advanced by 0.42% to $408.9 million in 2024, then increased by 0.44% to $410.7 million in 2025, then increased by 0.41% to $412.4 million in 2026.
- Business Quant data shows DXCM's Shares Outstanding (Entity) at $412.4 million in Q2 2026, $412.3 million in Q1 2026, and $410.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.90 Bn | 194.30 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 130.01 Bn | 126.54 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.53 Bn | 111.31 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.77 Bn | 74.24 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.43 Bn | 19.02 Bn | 1.54 Bn | 192.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 382.20 Mn |
| Mar 31, 2026 | 385.10 Mn |
| Dec 31, 2025 | 390.20 Mn |
| Sep 30, 2025 | 391.10 Mn |
| Jun 30, 2025 | 392.10 Mn |
| Mar 31, 2025 | 391.10 Mn |
| Dec 31, 2024 | 393.60 Mn |
| Sep 30, 2024 | 394.20 Mn |
| Jun 30, 2024 | 399.20 Mn |
| Mar 31, 2024 | 390.20 Mn |
| Dec 31, 2023 | 386.00 Mn |
| Sep 30, 2023 | 386.60 Mn |
| Jun 30, 2023 | 386.70 Mn |
| Mar 31, 2023 | 386.70 Mn |
| Dec 31, 2022 | 389.40 Mn |
| Sep 30, 2022 | 389.80 Mn |
| Jun 30, 2022 | 392.50 Mn |
| Mar 31, 2022 | 388.80 Mn |
| Dec 31, 2021 | 386.80 Mn |
| Sep 30, 2021 | 387.60 Mn |